{
    "code": "52026285",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026285",
    "time": "2023-04-07 03:45:18",
    "許可證字號": "衛部藥輸字第026285號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/03\/25",
    "發證日期": "103\/03\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202628505",
    "中文品名": "維帕特 100毫克膜衣錠",
    "英文品名": "Vimpat 100mg film-coated tablets",
    "適應症": "1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。\r\n2.輔助治療以下症狀：\r\n(1) 四歲以上複雜性局部癲癇發作(complex partial seizure)與單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人。\r\n(2) 四歲以上原發性全面強直陣攣發作(primary generalized tonic-clonic seizures; PGTCS)合併特發性全面癲癇發作(idiopathic generalized epilepsy)的病人。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "108\/03\/25",
    "主成分略述": "Lacosamide",
    "限制項目": "02輸　入 1E須執行Phase IV Study",
    "申請商名稱": "620101S739  台灣優時比貿易有限公司",
    "申請商地址": "台北市松山區南京東路三段287號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0024000  UCB PHARMA SA",
            "製造廠廠址": "CHEMIN DU FORIEST, 1420 BRAINE-L, ALLEUD, BELGIUM",
            "製造廠公司地址": "ALLEE DE LA RECHERCHE,60, 1070,BELGIUM",
            "製造廠國別": "BELGIUM",
            "製程": "成品製造、一級包裝、二級包裝"
        },
        {
            "製造廠名稱": "FDE0603000  Aesica Pharmaceuticals GmbH",
            "製造廠廠址": "Galileistrasse 6, D-08056 Zwickau, Germany",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FBE0061100  UCB PHARMA SA",
            "製造廠廠址": "ALLEE DE LA RECHERCHE 60, B-1070 BRUXELLES, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FDE9049000  AESICA PHARMACEUTICALS GMBH",
            "製造廠廠址": "Alfred-Nobel-Str. 10 and Mittelstr. 15, D-40789 Monheim, Germany",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "分裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812002300",
            "成分名稱": "Lacosamide",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "裸錠尺寸: 55 X125mm",
        "特殊劑型": "",
        "顏色": "暗黃色",
        "特殊氣味": "無味",
        "刻痕": "有",
        "形狀": "橢圓形",
        "標記一": "一邊刻有「SP」字紋",
        "標記二": "另一邊刻有「100」"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Vimpat 100裸錠尺寸照片-110-03-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026285&Seq=002&Type=10"
        },
        {
            "title": "Vimpat 100一般片裝照片-110-03-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026285&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI-Vimpat Tab_cn CCDS V3-110-07-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026285&Seq=009&Type=9"
        },
        {
            "title": "Vimpat 100一般片裝照片-110-03-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026285&Seq=005&Type=8"
        },
        {
            "title": "CIA76422E_ALU_VIMPAT_100MG_TAB_MON_TW_MU2-109-01-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026285&Seq=004&Type=8"
        },
        {
            "title": "CIA76426D_BOX_VIMPAT_100MG_56TAB_MON_TW_MU2_WinnRev-109-01-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026285&Seq=003&Type=8"
        }
    ]
}